|Bid||42.26 x 100|
|Ask||42.53 x 200|
|Day's Range||42.26 - 42.62|
|52 Week Range||35.52 - 42.62|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.07%|
Wall Street analysts estimate that GSK's top line will rise 11.4% to ~7.3 billion British pounds for 2Q17. Its EPS is expected come in at 0.26 pounds.
Can Vanguard dethrone BlackRock with the help of its low-cost funds and take the seat of the top asset manager?
Novartis (NVS) released its 2Q17 earnings on July 18, 2017. It reported flat revenues at constant exchange rates compared to 2Q16.